Analyst Ratings for Acorda Therapeutics Inc. (ACOR)

Updated: 2017-07-27

Shares of Acorda Therapeutics Inc. (NASDAQ:ACOR) have received a consensus rating of Overweight from Wall Street analysts. A consensus rating of Overweight was previously issued for ACOR last month.

8 analysts issued ratings on the stock, where 2 gave ACOR a buy rating, 0 issued an overweight rating, 6 gave a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 1. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Several price targets were given for ACOR by the analysts covering the stock. The most optimistic price target was 35, implying a possible profit of 61.29 percent. The most pessimistic analyst gave a price target of 17, implying potential capital losses of -21.66 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 3.15 percent. The average change in earnings estimates over the last 90 days is 75.62 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 2.05 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 26.1 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 1 analysts increased their quarterly estimates, while 2 analysts made negative revisions. Also over the last month, 1 analysts increased their estimates for the FY earnings, while 2 analysts made negative revisions to their fiscal year's estimates.

ACOR has traded between a high of 33.00 and a low of 13.60 over the past year. The current market price is above the trailing year's low by 59.56 percent, and below the high by 34.24 percent. ACOR has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The ACOR value stock report compares ACOR to some of its peers using value stock charts. The market cap of ACOR is $1.05 billion. ACOR's next earnings release will be on 0000-00-00, which is days away.